Sökning: WFRF:(Elshafie M) > Active Rheumatoid A...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04393naa a2200469 4500 | |
001 | oai:DiVA.org:uu-313419 | |
003 | SwePub | |
008 | 170119s2016 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3134192 URI |
024 | 7 | a https://doi.org/10.3899/jrheum.1603032 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a ElShafie, Amir Ibrahim,d 1970-u Uppsala universitet,Klinisk immunologi4 aut0 (Swepub:uu)amiel226 |
245 | 1 0 | a Active Rheumatoid Arthritis in Central Africa :b A Comparative Study Between Sudan and Sweden |
264 | c 2016-08-01 | |
264 | 1 | b The Journal of Rheumatology,c 2016 |
338 | a electronic2 rdacarrier | |
520 | a Objective. To compare clinical characteristics and treatment between simultaneously investigated Sudanese and Swedish outpatients with rheumatoid arthritis (RA).Methods. Outpatients with RA from Sudan (n = 281) and Sweden (n = 542) diagnosed according to the 1987 American College of Rheumatology criteria were recruited between December 2008 and September 2010 and compared concerning clinical presentation, treatment, and laboratory findings, including immunoglobulin M with rheumatoid factor (IgM-RF).Results. Sudanese patients had lower inclusion age (median 49 vs 68 yrs), disease duration (48 vs 107 mos), and disease onset age (43 vs 56 yrs) as compared with Swedish patients (p < 0.0001 for all). When stratified concerning the age of inclusion, Swedish patients between 41-50 years had, however, a significantly lower age of onset, with a similar trend for all age groups above 30 years. The female preponderance was higher among Sudanese patients (89.3% vs 72.5%, p < 0.0001), and smoking was nonexistent among Sudanese female patients (p < 0.0001). Erythrocyte sedimentation rate levels and number of tender joints were significantly higher among Sudanese patients. The proportion of IgM-RF positivity was lower among Sudanese patients with RA (52.4% vs 75.5%, p < 0.0001). Higher proportions of Sudanese patients with RA were treated with methotrexate (MTX) and disease-modifying antirheumatic drug combinations, but none of them used biologics. Sudanese patients used lower doses of MTX and sulfasalazine (p < 0.0001) and higher doses of prednisolone (p < 0.0001) than Swedish patients.Conclusion. Sudanese patients with RA have significantly higher disease activity and are often IgM-RF-seronegative. Together with reports from Uganda and Cameroon, our data indicate a cluster of highly active and often seronegative RA in central Africa. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng |
653 | a RHEUMATOID ARTHRITIS | |
653 | a SUDAN | |
653 | a DISEASE SEVERITY | |
653 | a RHEUMATOID FACTOR | |
653 | a DISEASE-MODIFYING ANTIRHEUMATIC DRUGS | |
700 | 1 | a Elkhalifa, Abdalla D.u Gavle Cent Hosp, Rheumatol Unit, Gavle, Sweden.4 aut |
700 | 1 | a Elbagir, Sahwau Uppsala universitet,Klinisk immunologi,Khartoum Fertil Ctr, Khartoum, Sudan.4 aut0 (Swepub:uu)sahel165 |
700 | 1 | a Aledrissy, Mawahib I. E.u Alribat Univ Hosp, Rheumatol Unit, Khartoum, Sudan.4 aut |
700 | 1 | a Elagib, Elnour M.u Mil Hosp, Rheumatol Unit, Omdurman, Sudan.4 aut |
700 | 1 | a Nur, Musa A. M.u Alribat Univ Hosp, Rheumatol Unit, Khartoum, Sudan.4 aut |
700 | 1 | a Weitoft, Tomasu Uppsala universitet,Centrum för klinisk forskning, Gävleborg,Gavle Cent Hosp, Rheumatol Unit, Gavle, Sweden4 aut0 (Swepub:uu)tomwe626 |
700 | 1 | a Rönnelid, Johanu Uppsala universitet,Klinisk immunologi4 aut0 (Swepub:uu)joharonn |
710 | 2 | a Uppsala universitetb Klinisk immunologi4 org |
773 | 0 | t Journal of Rheumatologyd : The Journal of Rheumatologyg 43:10, s. 1777-1786q 43:10<1777-1786x 0315-162Xx 1499-2752 |
856 | 4 | u https://doi.org/10.3899/jrheum.160303y Fulltext |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1068560/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u http://www.jrheum.org/content/jrheum/43/10/1777.full.pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-313419 |
856 | 4 8 | u https://doi.org/10.3899/jrheum.160303 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy